misiu, a $16M "settlement" with shareholders (including attorneys) makes no sense IF actual losses "were very small."

Additionally, the perpetrators responsible for the accused wrongful acts have long since been purged from the company. I see the fact that management saw fit to settle this now (as soon as they had the additional shares to do so), as a VERY positive move, not to mention getting rid of the associated baggage of it's existence. Now other potential "partners" are free to explore possibilities with CytoDyn, should they see value in LL. JMHO